Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has approved the buyback of up to 1,394,000 equity shares at a price not exceeding ₹500 per share, and the acquisition of the remaining 4.28% stake in its subsidiary JC Biotech Private Limited. The company has also approved the infusion of up to ₹20 million in its subsidiary Advanced Nutrazyme Private Limited.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026. The Board has approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026. Additionally, the Board has approved the Buyback of fully paid-up equity shares having a face value of ? 2/- (Rupees Two only) each of the Company at a price not exceeding ? 500/- (Rupees Five Hundred only) per equity share. The Board has also approved the acquisition of the remaining stake of 4.28% Equity Shares from the other existing Shareholders of JC Biotech Private Limited and the infusion of additional funds not exceeding ? 20 million in Advanced Nutrazyme Private Limited.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has submitted its financial results for the quarter ended June 30, 2026, and approved a buyback of equity shares, acquisition of a remaining stake in JC Biotech Private Limited, and infusion of additional funds in Advanced Nutrazyme Private Limited.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has scheduled a conference call to discuss its un-audited financial results for the quarter ended June 30, 2026, on August 12, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about the outcome of its 37th Annual General Meeting, where the members approved the re-appointment of the Whole Time Director, appointment of an Independent Director, and re-appointment of the Statutory Auditors.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has submitted the Scrutinizer's report and voting results of the 37th Annual General Meeting held on July 31, 2026, where all resolutions were passed with the requisite majority.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited held its 37th Annual General Meeting on July 31, 2026, through Video Conference. The meeting was attended by 106 members, and the required quorum was present. The company declared a final dividend of ₹ 1.35 per equity share for the financial year ended March 31, 2026. The meeting also approved the appointment of a director, reappointment of statutory auditors, and other resolutions.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming securities received for dematerialisation during the quarter ended June 30, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about a copy of newspaper publication regarding the 37th Annual General Meeting (AGM) and Remote e-voting facility.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange regarding the sending of a letter to shareholders who have not registered their email addresses with the Company/Registrar & Share Transfer Agent/Depositories, providing a web-link to access the Integrated Annual Report for FY 2025-26 and the Notice of 37th Annual General Meeting.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26, as per the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 31, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about a copy of newspaper publication regarding the 37th Annual General Meeting of the Company to be held on July 31, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has informed the Exchange about the date of the 37th Annual General Meeting of the Company, which will be held on July 31, 2026, through Video Conference / Other Audio Visual Means. The Record Date for the final Dividend of ₹ 1.35/- per Equity Share of ₹ 2/- each for the financial year 2025-26 has been fixed as July 24, 2026.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has announced the record date for the purpose of dividend payment as July 24, 2026, for the financial year 2025-26. The company will hold its 37th Annual General Meeting on July 31, 2026, through video conference or other audio visual means.

Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has closed its trading window for insiders due to SEBI regulations, effective from July 1, 2026, until 48 hours after the announcement of its Q2 FY2026 financial results.